Zobrazeno 1 - 10
of 16
pro vyhledávání: '"MASOOD shammas"'
Autor:
Nawaf Alanazi, Abdulaziz Siyal, Sulman Basit, Masood Shammas, Sarah Al-Mukhaylid, Aamer Aleem, Amer Mahmood, Zafar Iqbal
Publikováno v:
Hematology Reports, Vol 16, Iss 3, Pp 465-478 (2024)
Background: Chronic myeloid leukemia (CML) results from chromosomal translocation t(9;22) leading to the formation of the BCR-ABL fusion oncogene. CML has three stages: the chronic phase (CP), the accelerated phase (AP), and the blast crisis (BC). Ty
Externí odkaz:
https://doaj.org/article/3f2b0a7e08d248c5a9dd96e59df88ae7
Autor:
Zafar Iqbal, Muhammad Absar, Tanveer Akhtar, Aamer Aleem, Abid Jameel, Sulman Basit, Anhar Ullah, Sibtain Afzal, Khushnooda Ramzan, Mahmood Rasool, Sajjad Karim, Zeenat Mirza, Mudassar Iqbal, Maryam AlMajed, Buthinah AlShehab, Sarah AlMukhaylid, Nouf AlMutairi, Nawaf Al-anazi, Muhammad Farooq Sabar, Muhammad Arshad, Muhammad Asif, Masood Shammas, Amer Mahmood
Publikováno v:
Biology, Vol 10, Iss 11, p 1182 (2021)
Background: Chronic myeloid leukemia (CML) is initiated in bone marrow due to chromosomal translocation t(9;22) leading to fusion oncogene BCR-ABL. Targeting BCR-ABL by tyrosine kinase inhibitors (TKIs) has changed fatal CML into an almost curable di
Externí odkaz:
https://doaj.org/article/f81fb94a73054ad086543f8318509d8f
Autor:
Jagannath Pal, Yogita Rajput, Arvind Neral, Nikita Sherwani, Vijaylakshmi Jain, Malti Sahu, Fulsay Paikra, Heeramani Lodhi, Ravindra Panda, Vinit Jain, Omprakash sundrani, MASOOD shammas
Unpredictable fatal outcome of COVID-19 is attributed to dysregulated inflammation. The purpose of this study was to develop biomarkers for early detection of host immune impairment which may in turn identify high risk patients. We used RT-PCR to eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c30d97c6f659ef5960f51cf4d15121d
https://doi.org/10.21203/rs.3.rs-2833478/v1
https://doi.org/10.21203/rs.3.rs-2833478/v1
Autor:
Eugenio Morelli, Annamaria Gulla, Na Liu, Megan Johnstone, Delaney Vinaixa, Doriana Gramegna, Kenneth Wen, Yu-Tzu Tai, Dharminder Chauhan, Mehmet Samur, Masood Shammas, Mariateresa Fulciniti, Sergei Gryaznov, Kenneth Anderson, Nikhil Munshi
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S94-S95
Autor:
Thomas Smits, Anil Aktas Samur, Romain Lannes, Mariateresa Fulciniti, Masood Shammas, Jill Corre, Kenneth Anderson, Giovanni Parmigiani, Hervé Avet-Loiseau, Nikhil Munshi, Mehmet Samur
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S10-S11
Autor:
Chengcheng Liao, Srikanth Talluri, Shidai Mu, Jiangning Zhao, Subodh Kumar, Jailan Shi, Leutz Buon, Masood Shammas, Nikhil Munshi
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S73
Autor:
Shidai Mu, Srikanth Talluri, Jiangning Zhao, Leutz Buon, Mehmet Samur, Masood Shammas, Nikhil Munshi
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S74
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S12
Autor:
Chandraditya Chakraborty, Srikanth Talluri, Eugenio Morelli, Sanika Derebail, Yan Xu, Charles Epstein, Thomas Smits, Moritz Binder, Kenneth Anderson, Masood Shammas, Mehmet Samur, Mariateresa Fulciniti, Nikhil Munshi
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S8
Autor:
Maria Gkotzamanidou, Masood Shammas, Jesus Martin Sanchez, Lai Ding, Stephane Minvielle, Florence Magrangeas, Herve Avet-Loiseau, Kenneth C. Anderson, Nikhil C. Munshi
Publikováno v:
Blood. 124:416-416
Epigenomic changes have become an important component of cellular regulation and ultimately, of our understanding of oncogenomics in Multiple Myeloma (MM) as well as in other cancers. In recent years, both clinical and preclinical studies have confir